Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus

Chowdhury, KR; Michaud, J; Yu, OHY; Yin, H; Azoulay, L; Renoux, C

Renoux, C (通讯作者),Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, 3755 Cote St Catherine H 416-1, Montreal, PQ H3T 1E2, Canada.

THROMBOSIS AND HAEMOSTASIS, 2022; 122 (10): 1794

Abstract

Aims To evaluate the effectiveness and safety of apixaban versus rivaroxaban among patients with nonvalvular atrial fibrillation (NVAF) and type 2 dia......

Full Text Link